What is the appropriate management for a patient with peanut allergy, including avoidance strategies, epinephrine auto‑injector prescription, antihistamine use, emergency action plan, and referral to an allergist?

Management of Peanut Allergy

All patients with confirmed peanut allergy must be prescribed an epinephrine auto-injector (0.15 mg for 10-25 kg; 0.3 mg for >25 kg), receive comprehensive avoidance education, have a written emergency action plan, and be referred to an allergist for ongoing management 1, 2.

Immediate Prescriptions and Education

Epinephrine Auto-Injector

• Prescribe based on weight: 0.15 mg for patients 10-25 kg; 0.3 mg for patients >25 kg 1
• Epinephrine is the first-line treatment for anaphylaxis—there are no contraindications in life-threatening situations 2, 3
• Administer intramuscularly into the anterolateral thigh (vastus lateralis) only—never buttock, digits, hands, or feet 3
• Doses may be repeated every 5-15 minutes if symptoms persist 1
• Most patients stabilize within 15 minutes of epinephrine use and do not require a second dose 4

Critical teaching point: The 2024 anaphylaxis guidelines now support contextualized care—not all patients who use epinephrine require immediate emergency department transport. Patients can observe for response over 15 minutes before deciding on emergency care, which is more cost-effective 4. However, patients with cardiovascular symptoms, respiratory compromise, or incomplete response must activate emergency services immediately 2.

Adjunctive Medications

• H1 antihistamines (diphenhydramine 1-2 mg/kg, max 50 mg) are adjunctive only—never first-line 1
• Antihistamines may be used for mild cutaneous symptoms but do not prevent or treat anaphylaxis 2
• Do not prescribe antihistamines as standalone treatment for peanut allergy management

Avoidance Strategies

Dietary Counseling

• Strict peanut avoidance is the cornerstone of management 5, 6
• Educate on reading food labels—peanut must be declared on prepacked products, but cross-contamination labeling is inconsistent 6
• Hidden peanut sources include Asian cuisine, baked goods, sauces, and processed foods
• Severity correlates with amount ingested—even trace amounts can trigger reactions in highly sensitive individuals 7

Risk Context

• Unintentional exposures occur at a rate of approximately 0.33 per year (1 every 3 years) 1
• 39% of diagnosed patients experience unintentional exposure after diagnosis 1
• Most reactions (73%) are initially non-life-threatening, but severity can escalate 1

Written Emergency Action Plan

Provide a personalized plan that includes:

• Recognition of early symptoms: flushing, urticaria, angioedema, throat tightness, wheezing, vomiting, diarrhea, hypotension 3
• When to use epinephrine: respiratory symptoms (wheezing, throat tightness), cardiovascular symptoms (hypotension, syncope), or involvement of two or more organ systems 2
• Dosing instructions specific to patient weight
• When to call 911: severe symptoms, incomplete response to first epinephrine dose, or patient preference for immediate evaluation
• Position patient recumbent with lower extremities elevated if tolerated 1

Allergist Referral

All patients require specialist assessment 2, 5:

• Confirm diagnosis with skin prick testing (SPT ≥8 mm) or specific IgE (≥15 kU/L for peanut) 5
• These cutoffs are highly predictive of clinical allergy, though test magnitude does not predict reaction severity 5
• Reassess periodically—approximately 20% of children may outgrow peanut allergy, though this is less common than with milk or egg allergy 1
• Consider oral immunotherapy (OIT) in select cases, though it increases risk of anaphylaxis (RR 2.27) and epinephrine use (RR 2.05) during treatment 8

Common Pitfalls

• Never delay epinephrine for antihistamines—epinephrine is always safe even if diagnosis is uncertain 2
• Avoid injecting into buttock—this increases risk of Clostridial infection (gas gangrene) and may not provide effective treatment 3
• Do not rely on antihistamine premedication—there is no evidence supporting routine premedication to prevent anaphylaxis 2
• Retrain regularly—patients and families require ongoing education on recognition and treatment 7
• Patients with asthma, cardiovascular disease, or older age are at higher risk for severe reactions 2

Special Considerations

• Sulfite sensitivity: Epinephrine contains sodium bisulfite, but this should never preclude use in anaphylaxis 3
• Comorbid conditions: Use epinephrine with awareness (not contraindication) in patients with heart disease, hypertension, hyperthyroidism, or Parkinson's disease 3
• School environment: Ensure school staff receive training on recognition and treatment of allergic reactions 6